ABOUT

A Talented, Experienced and Global Team

Executive Management

Roi Raz
CEO

  • +15 years’ experience in biotech equity research and corporate development

  • Ex. Moderna, Portfolio Manager at Adamas Capital Management & Atonra Partners

Jukka Tuominen
D.Sc. Eng., CTO

  • 25+ yrs experience developing novel biomaterials, including for Cervidil®/ Propess; 10 patents; 40+ publications

  • Previously Principal Scientist at Corbion Purac responsible for science & development programs

Harri Jukarainen
M.Sc. Eng., CSO/MD

  • 25+ years experience in polymer-based sustained release formulation development; 30+ patents/publications

  • Previously Scientist at Bayer developing innovative controlled drug delivery platforms

Kristof Kunzmann
MBA, CFO

  • 12+ years CFO/COO experience in start-up and scale-up healthcare businesses

  • Specialist multi-site diagnostic, genetic and in-vitro labs

Board of Directors

Robert Watson
D.Phil (Oxon), Board Chairman

  • 20+ yrs experience in life sciences investment and strategy

  • Co-founder/Managing Partner of Gyrus Capital

  • Previously Managing Director at Altaris Capital Partners, Ares Life Sciences, and Sofinnova Partners

Jonathan Glen
Founder, Board Member

  • Chairman of PiBond Oy, semiconductor polymer manufacturer

  • Founder of ReneSola SOL NYSE

  • Chairman of Aleva Neurotherapeutics SA

Kristoffer Andenaes
Co-Founder, Board Member

  • Leading Scandinavian investor with focus on CleanTech and MedTech

  • Runs a family office in Oslo, Norway with interests in a portfolio of private and public companies

Patrick Aisher
Non-Executive Board Member

  • Chairman of Kinled Holding in Hong Kong, which retains a portfolio of 100+ investments in the life science, digital, and financial technology industries

  • Co-founder CEBINA (Central European Biotechnology Incubator and Accelerator) in Vienna, and Mountain Labs AG in Zürich

World-Class Scientific Advisors

EXPERTS FOCUSED ON THE EYE

Arto Urtti
Ph.D

Professor of Biopharmaceutics (Ophthalmic), University of Eastern Finland; Director, Centre for Drug Research, University of Helsinki

Mandeep S. Sagoo
MB, Ph.D, MRCOphth

Professor of Ophthalmology and Ocular Oncology, UCL Institute of Ophthalmology; Consultant Ophthalmic Surgeon, Moorfields Eye Hospital & Barts Health NHS Trust

Hari Jayaram
MRCOphth, Ph.D

Director, Glaucoma Service; Co-Chair Research Management Committee Moorfields Eye Hospital (NHS) London